5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 25.14▼ | 25.21▼ | 25.21▼ | 25.49▼ | 24.85▲ |
MA10 | 25.17▼ | 25.24▼ | 25.42▼ | 25.26▼ | 24.87▲ |
MA20 | 25.20▼ | 25.47▼ | 25.63▼ | 24.65▲ | 24.09▲ |
MA50 | 25.24▼ | 25.60▼ | 25.41▼ | 24.71▲ | 25.53▼ |
MA100 | 25.41▼ | 25.40▼ | 24.99▲ | 23.91▲ | 27.04▼ |
MA200 | 25.63▼ | 24.94▲ | 24.70▲ | 25.00▲ | 36.57▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.007▼ | -0.033▼ | -0.091▼ | 0.100▲ | 0.263▲ |
RSI | 28.528▼ | 25.663▼ | 34.114▼ | 53.484▲ | 51.775▲ |
STOCH | 15.494▼ | 13.349▼ | 4.686▼ | 76.832 | 58.548 |
WILL %R | -87.097▼ | -97.403▼ | -98.000▼ | -43.111 | -31.803 |
CCI | -90.111 | -102.763▼ | -96.644 | 58.832 | 86.436 |
Monday, August 25, 2025 09:59 PM
The Washington State Employment Security Department has said that 100 workers are affected by Pfizer’s (NYSE:PFE) layoff, according to a WARN notice. Elsewhere, President Donald Trump told reporters ...
|
Monday, August 25, 2025 09:41 PM
Pfizer stock is undervalued with strong non-COVID growth, robust Q2 2025 results, and strategic R&D pivots. See more on PFE stock here.
|
Monday, August 25, 2025 07:02 PM
Despite the positive outlook, Pfizer still faces substantive execution risks. The looming challenge of losing exclusivity on certain drugs could impact revenue streams significantly. Moreover, while ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
25/08/25 | 25.88 | 25.89 | 25.11 | 25.14 | 32,666,100 |
22/08/25 | 25.90 | 26.11 | 25.76 | 25.88 | 34,545,300 |
21/08/25 | 25.41 | 25.89 | 25.37 | 25.74 | 37,054,600 |
20/08/25 | 25.39 | 25.69 | 25.34 | 25.38 | 38,059,100 |
19/08/25 | 25.14 | 25.43 | 25.10 | 25.32 | 29,158,400 |
18/08/25 | 25.14 | 25.23 | 25.01 | 25.07 | 35,614,900 |
15/08/25 | 25.22 | 25.30 | 24.97 | 25.14 | 31,824,800 |
14/08/25 | 25.09 | 25.18 | 24.82 | 25.11 | 32,465,600 |
13/08/25 | 24.75 | 25.20 | 24.74 | 25.16 | 40,158,000 |
12/08/25 | 24.66 | 24.77 | 24.47 | 24.65 | 34,402,700 |
|
|
||||
|
|
||||
|
|